James Trager

Chief Scientific Officer, Nkarta Therapeutics (United States).

Companies

Nkarta Therapeutics (United States)Chief Scientific Officer Jul 9, 2020 to Jun 20, 2024¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Nkarta Therapeutics (United States) NKTX150,959 shares²$291.4K at $1.93Jun 18, 2024

As of each latest filing. The line shows shares held over time.

Jun 18, 2024Sold 456 shares at $5.60 of Nkarta Therapeutics (United States)²
Feb 12, 2024Sold 4,143 shares at $12.00 of Nkarta Therapeutics (United States)³
Jan 16, 2024Sold 4,560 shares at $8.74 of Nkarta Therapeutics (United States)⁴
Jan 4, 2024Granted 56,000 shares of Nkarta Therapeutics (United States)⁵
Jun 20, 2023Sold 439 shares at $4.85 of Nkarta Therapeutics (United States)⁶
Jan 17, 2023Sold 1,115 shares at $5.49 of Nkarta Therapeutics (United States)⁷
Jan 13, 2023Granted 37,500 shares of Nkarta Therapeutics (United States)⁷
Aug 15, 2022Sold 5,000 shares at $17.53 of Nkarta Therapeutics (United States)⁸
Aug 15, 2022Exercised options 5,000 shares at $3.89 of Nkarta Therapeutics (United States)⁸
Jun 17, 2022Granted 5,000 shares of Nkarta Therapeutics (United States)⁹
Jan 14, 2022Granted 12,800 shares of Nkarta Therapeutics (United States)¹⁰

The numbers on this page point here. Each one links to the record it came from.